Edman Degradation vs MS/MS for N-Terminal Peptide Sequencing

Two techniques can read a peptide’s sequence directly from the material rather than inferring it from a mass. Edman degradation, published by Pehr Edman in 1950, removes and identifies one residue at a time from the N-terminus. Tandem mass spectrometry fragments the whole chain in the gas phase and reads the sequence from the spacing of the fragments. Both answer the question “what order are the residues in,” but they fail in different places, which is why each still has a role.

The Edman cycle, one residue per turn

Each Edman cycle has three chemical steps. Phenyl isothiocyanate couples to the free N-terminal amine under mildly basic conditions, forming a phenylthiocarbamyl peptide. Anhydrous acid then cleaves the first peptide bond, releasing the terminal residue as an anilinothiazolinone and leaving a peptide one residue shorter with a new free amine. The released derivative is converted in aqueous acid into the more stable phenylthiohydantoin (PTH) amino acid, which is identified by its retention time on a dedicated HPLC system against PTH standards.

An automated sequencer repeats the cycle, reporting the identity of residue 1, then residue 2, and so on. Modern instruments work with low-picomole sample amounts, and each cycle typically takes well under an hour.

Why Edman reads fade after a few dozen cycles

No cycle is perfectly efficient. A small fraction of chains fails to couple or cleave in each round, falls one step behind and contributes a lagging signal in later cycles. Meanwhile the fraction of chains still in step shrinks geometrically with the repetitive yield.

Repetitive yield per cycleSignal left after 20 cyclesSignal left after 40 cycles
95%36%13%
98%67%45%

An analyst reading cycle 15 therefore sees the expected PTH derivative plus a smaller peak for the residue from cycle 14, carried by chains that fell behind. With a clean, pure sample the pattern is predictable and easy to subtract; with a partly degraded or impure sample it is not. As the true signal falls and the lagging background rises, the two converge and calls become ambiguous. That is why practical Edman reads are usually limited to a few tens of residues, and why longer chains are sequenced as fragments after digestion, an approach related to peptide mapping.

Blocked N-termini and other Edman blind spots

The chemistry needs a free alpha-amino group. An N-terminal acetyl group, a pyroglutamate ring or a formyl group stops the reaction at cycle one, and the instrument reports nothing at all. Many synthetic peptides are deliberately acetylated, as described in terminal modifications, so Edman is simply not applicable to them without first removing the block.

Other limitations follow from the PTH identification step. Unmodified cysteine gives a poor signal unless it has been alkylated first. Some modified residues, such as phosphoserine, do not survive as a clean PTH derivative. A mixture of two sequences produces two PTH signals per cycle, which can be deconvoluted only when one component clearly dominates. The method also says nothing about the C-terminus, so a C-terminal amide has to be confirmed by mass.

How tandem mass spectrometry reads the same chain

In MS/MS, a selected precursor ion is fragmented, most often by collision-induced dissociation, which breaks backbone amide bonds to give b ions containing the N-terminus and y ions containing the C-terminus. The mass difference between consecutive ions in either series equals one residue mass, so the sequence is read from the ladder. If two consecutive b ions differ by 57.021 Da, that position is glycine; a step of 71.037 Da indicates alanine, and 87.032 Da serine. The fundamentals are covered in tandem mass spectrometry for peptide sequencing.

The strengths are mostly where Edman is weak. MS/MS does not care whether the N-terminus is blocked. It works on femtomole to picomole quantities, takes seconds per spectrum, and when coupled to liquid chromatography it handles mixtures by separating them first. Modifications are located from the mass shift they cause on the fragments that contain them.

Where MS/MS needs help from other evidence

  • Leucine and isoleucine. Both have a residue mass of 113.084 Da, so ordinary b and y ladders cannot tell them apart. Edman separates the two PTH derivatives chromatographically; in mass spectrometry, specialized fragmentation that produces side-chain-specific ions is needed.
  • Glutamine and lysine. Their residue masses differ by about 0.036 Da, which needs good resolution and mass accuracy to resolve reliably.
  • Fragment gaps. A missing cleavage leaves two residues whose order cannot be read from that spectrum. Proline-rich regions and short dipeptide segments at the ends are common trouble spots.
  • Isomers of the same residue. Aspartate and isoaspartate share a mass, as do L- and D-residues. Neither technique distinguishes D from L in routine use; that problem is covered in racemization and chiral purity.

Choosing between Edman and MS/MS

SituationBetter suited
Acetylated or pyroglutamate N-terminusMS/MS
Confirming the first 10 to 20 residues of a pure, unblocked chain, including Leu versus IleEdman
Locating a modification anywhere in the chainMS/MS
Mixture of related sequencesLC-MS/MS
Independent confirmation of an MS-derived N-terminal sequenceEdman

In practice MS/MS has become the default because of its speed, sensitivity and tolerance of blocked termini, while Edman remains the chemical reference for N-terminal sequence in characterization work. For routine supply, a correct intact mass together with a clean purity chromatogram is the usual evidence. Battle Born posts one independent reverse-phase HPLC purity result per product, with no lot designation on the vial; a vial’s crimp and cap color identify which published result applies to it.

Frequently asked questions

Why does Edman degradation fail on some peptides?

It needs a free N-terminal amine. Acetylated, formylated or pyroglutamate-terminated peptides give no sequence at all unless the block is removed.

Can MS/MS distinguish leucine from isoleucine?

Not with ordinary b and y ions, because the two residues have identical mass. Specialized fragmentation methods can, and Edman separates them directly.

How many residues can Edman sequencing read?

It depends on repetitive yield and sample quality, but reads are usually limited to a few tens of residues before signal and background converge.


Research use only. All products supplied by Battle Born Peptides are laboratory reference materials for in-vitro research and analytical use by qualified professionals. They are not drugs, foods, dietary supplements, cosmetics or medical devices; they are not approved by the FDA or any other regulator for use in humans or animals; and they are not intended to diagnose, treat, cure, mitigate or prevent any disease, or to affect the structure or any function of the body of humans or animals. Nothing in this article is preparation, handling or dosing guidance. See our full research-use terms.